4//SEC Filing
GUETH ANTON 4
Accession 0001209191-21-030644
CIK 0001016169other
Filed
May 5, 8:00 PM ET
Accepted
May 6, 4:53 PM ET
Size
7.1 KB
Accession
0001209191-21-030644
Insider Transaction Report
Form 4
GUETH ANTON
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2021-05-04−40,000→ 0 totalExercise: $1.66Exp: 2021-05-16→ Common Stock (40,000 underlying) - Exercise/Conversion
Common Stock
2021-05-04$1.66/sh+40,000$66,400→ 542,125 total
Footnotes (1)
- [F1]The options vested in four equal quarterly installments from the grant date of May 17, 2011. The stock options were due to expire on May 16, 2021.
Documents
Issuer
ANTARES PHARMA, INC.
CIK 0001016169
Entity typeother
Related Parties
1- filerCIK 0001274940
Filing Metadata
- Form type
- 4
- Filed
- May 5, 8:00 PM ET
- Accepted
- May 6, 4:53 PM ET
- Size
- 7.1 KB